genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
30 March 2021
Interim Report and Accounts 31 December 2020
View all reports >
Saturday May 01, 2021
Small cap movers: Blackbird makes inroads into US news market; gendrive beats Abingdon Health in diagnostics shoot-out
Friday April 30, 2021
FTSE 100 closes on the front foot, with AstraZeneca the top riser
Proactive news headlines: Gfinity, Synairgen, Chaarat Gold, Destiny Pharma...
View all news >
On the 8th June 2018 Genedrive Plc disposed of the business and assets of Epistem Ltd. Please follow this link to be redirected to the website of Epistem Ltd
© 2017-21 genedrive plc
Don't show this again